Breaking Ground: ABVC BioPharma Receives $200,000 in Initial Licensing Payment from Oncology Partner, Totaling $546,000 from Three Partners
Exciting News in the Biopharmaceutical Industry ABVC BioPharma Receives Cash Payment from OncoX BioPharma FREMONT, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) — ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic solutions in ophthalmology, CNS (central nervous system), and oncology/hematology, announced the receipt of a $200,000 cash payment from OncoX BioPharma Inc. (“OncoX”)…